<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04888689</url>
  </required_header>
  <id_info>
    <org_study_id>ActiSEP. Part 1.</org_study_id>
    <nct_id>NCT04888689</nct_id>
  </id_info>
  <brief_title>Holter of Movement in Patients With Multiple Sclerosis in Controlled Environment.</brief_title>
  <official_title>Holter of Movement in Patients With Multiple Sclerosis. Acti-SEP Study: Controlled Environment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Stéphanie Delstanche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sysnav</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Liege</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Régional de la Citadelle</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be&#xD;
      included on a voluntary basis. We plan to include a group of approximately 20 patients with&#xD;
      MS.&#xD;
&#xD;
      This study include a unique evaluation in the laboratory of analysis of human movement. A set&#xD;
      of tasks will be performed by patients wearing of two magneto-inertial sensors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 4, 2021</start_date>
  <completion_date type="Anticipated">February 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 4, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>all patients undergo clinical evaluation while wearing Actimyo device to assess their gait.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>95th centile of stride velocity</measure>
    <time_frame>One day</time_frame>
    <description>95th centile of stride velocity obtained with magneto-inertial sensors and a motion capture device (meter/second).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>50th centile of stride velocity</measure>
    <time_frame>One day</time_frame>
    <description>50th centile of stride velocity obtained with magneto-inertial sensors and a motion capture device (meter/second).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>95th centile of stride length</measure>
    <time_frame>One day</time_frame>
    <description>95th centile of stride length obtained with magneto-inertial sensors and a motion capture device (meter).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>50th centile of stride length</measure>
    <time_frame>One day</time_frame>
    <description>50th centile of stride length obtained with magneto-inertial sensors and a motion capture device (meter).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance phase time</measure>
    <time_frame>One day</time_frame>
    <description>Stance time over full stride time for each foot obtained with magneto-inertial sensors and a motion capture device (percentage).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>MS patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ambulant patients with multiple sclerosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Actimyo°</intervention_name>
    <description>Actimyo° is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.</description>
    <arm_group_label>MS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IMU</intervention_name>
    <description>IMU is a portable system of miniaturized inertial sensors for objective, instrumental, ambulatory, and validated analysis of normal and pathological human gait. Each miniaturized inertial sensor (2 cm × 0.7 cm × 0.5 cm) includes a triaxial accelerometer and a triaxial gyroscope.&#xD;
These four inertial sensors are connected to a box by wires and are numbered 1 to 4. They must be attached - using adhesive tapes - on the participant's shoes.</description>
    <arm_group_label>MS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed MS diagnosis,&#xD;
&#xD;
          -  Over 18 years old,&#xD;
&#xD;
          -  Ambulant patients,&#xD;
&#xD;
          -  Signed informed consent,&#xD;
&#xD;
          -  No clinical and / or radiological relapse within 3 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with excessive cognitive disorders, limiting the understanding of task or&#xD;
             with apparent communication difficulties hindering data collection.&#xD;
&#xD;
          -  Any other previous or present pathology having an impact on motor function.&#xD;
&#xD;
          -  Recent surgery or trauma (less than 6 months) in the upper or lower limbs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaux Poleur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Citadelle-CHU liège</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Régional de la Citadelle</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laboratoire d'Analyse du Mouvement Humain</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Régional de la Citadelle</investigator_affiliation>
    <investigator_full_name>Dr. Stéphanie Delstanche</investigator_full_name>
    <investigator_title>Coordinator of reference center for neuromuscular diseases</investigator_title>
  </responsible_party>
  <keyword>Actimyo</keyword>
  <keyword>Accelerometry</keyword>
  <keyword>Motion laboratory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

